Cargando…
Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
BACKGROUND: In December 2020, Moderna released the mRNA-1273 vaccine. The most common side effects are headache, muscle pain, redness, swelling, and tenderness at the injection site. In addition, there have been dermatological adverse events, such as hypersensitivity reactions. Although rare, variou...
Autores principales: | Kong, Joyce, Cuevas-Castillo, Francisco, Nassar, Mahmoud, Lei, Chi M., Idrees, Zarwa, Fix, William C., Halverstam, Caroline, Mir, Adnan, Elbendary, Amira, Mathew, Alwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264280/ https://www.ncbi.nlm.nih.gov/pubmed/34294590 http://dx.doi.org/10.1016/j.jiph.2021.06.021 |
Ejemplares similares
-
mrna-1273: Bullous drug eruption: case report
Publicado: (2021) -
Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022) -
Cutaneous Sarcoidosis-like Eruption Following Second Dose of Moderna mRNA-1273 Vaccine: Case or Relationship?
por: Cazzato, Gerardo, et al.
Publicado: (2023) -
Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
por: Karatas, Elif, et al.
Publicado: (2022) -
De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)